Status:
COMPLETED
High Density Scar Guided Atrial Fibrillation Mapping
Lead Sponsor:
University Hospital Southampton NHS Foundation Trust
Collaborating Sponsors:
Boston Scientific Corporation
Abbott
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
HD SAGA: There is increasing evidence that having AF is associated with some scarring of the upper chamber of the heart, the left atrium. There is also evidence that the amount of scarring can predic...
Detailed Description
HD SAGA: The study would propose to use the Rhythmia Ultra High Density (UHD) mapping system (Boston Scientific) firstly to generate scar maps to determine if the results are comparable with previous...
Eligibility Criteria
Inclusion
- trial Fibrillation, Scheduled for ablation on clinical grounds Able/willing to consent to procedure/research protocol No contraindication to clinical ablation
Exclusion
- Unable/unwilling to consent Contraindication to clinical ablation
Key Trial Info
Start Date :
August 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03363087
Start Date
August 27 2019
End Date
March 1 2023
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Southampton
Southampton, Hampshire, United Kingdom, SO16 6YD